These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 32461441)
41. Visual Prognostic Factors of Epiretinal Membrane Surgery in Patients with Pseudophakia. Kim JY; Kim DY; Kim KT; Song J; Chae JB; Kim JG Ophthalmologica; 2020; 243(1):43-50. PubMed ID: 31554000 [TBL] [Abstract][Full Text] [Related]
42. Epiretinal membrane after pars plana vitrectomy for primary pseudophakic or aphakic rhegmatogenous retinal detachment: incidence and outcomes. Martínez-Castillo V; Boixadera A; Distéfano L; Zapata M; García-Arumí J Retina; 2012 Jul; 32(7):1350-5. PubMed ID: 22414957 [TBL] [Abstract][Full Text] [Related]
43. LONG-TERM OUTCOMES OF 23-GAUGE PARS PLANA VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING AND GAS TAMPONADE FOR MYOPIC TRACTION MACULOPATHY: A Prospective Study. Figueroa MS; Ruiz-Moreno JM; Gonzalez del Valle F; Govetto A; de la Vega C; Plascencia RN; Contreras I; Medina JL Retina; 2015 Sep; 35(9):1836-43. PubMed ID: 25946689 [TBL] [Abstract][Full Text] [Related]
45. Postoperative restoration of foveal inner retinal configuration in patients with epiretinal membrane and abnormally thick inner retina. Yang HS; Kim JT; Joe SG; Lee JY; Yoon YH Retina; 2015 Jan; 35(1):111-9. PubMed ID: 25102192 [TBL] [Abstract][Full Text] [Related]
46. Impact of intravitreal triamcinolone injection following epiretinal membrane peeling on ectopic inner foveal layer classification. Su D; Li HN; Chen QC; Shen DP; Huang ZT Eur J Ophthalmol; 2024 Sep; 34(5):1541-1547. PubMed ID: 38204151 [TBL] [Abstract][Full Text] [Related]
47. Outcome of Intravitreal Dexamethasone Implant Use in Uveitic Eyes Undergoing Pars Plana Vitrectomy Surgery. Kirkland KA; Uwaydat SH; Siddiqui MZ; Chancellor JR; Soliman MK; Kurup S; Sallam AB Ocul Immunol Inflamm; 2021 Aug; 29(6):1126-1131. PubMed ID: 32142385 [No Abstract] [Full Text] [Related]
48. The long-term anatomical and visual effect of intravitreal triamcinolone injection during vitrectomy for the treatment of idiopathic macular epiretinal membrane. Lai CC; Wang NK; Wu WC; Yeung L; Hwang YS; Chen KJ; Chen TL; Chuang LH Cutan Ocul Toxicol; 2011 Dec; 30(4):292-7. PubMed ID: 21449851 [TBL] [Abstract][Full Text] [Related]
49. [Intravitreal dexamethasone implant for treatment of persistent postoperative macular edema after vitrectomy]. Hattenbach LO; Kuhli-Hattenbach C; Springer C; Callizo J; Hoerauf H Ophthalmologe; 2016 Jul; 113(7):581-8. PubMed ID: 26879555 [TBL] [Abstract][Full Text] [Related]
50. 20 g PPV with indocyanine green-assisted ILM peeling versus 23 g PPV with brilliant blue G-assisted ILM peeling for epiretinal membrane. Manousaridis K; Peter S; Mennel S Int Ophthalmol; 2016 Jun; 36(3):407-12. PubMed ID: 26499510 [TBL] [Abstract][Full Text] [Related]
51. [Intraoperative risk factors associated with visual acuity outcomes of pars plana vitrectomy in idiopathic epiretinal membrane]. Li HH; Liao X; Xie CL; Gao XR; Wang H; Wang F Zhonghua Yan Ke Za Zhi; 2017 May; 53(5):344-351. PubMed ID: 28494562 [No Abstract] [Full Text] [Related]
52. Effect of air and sulfur hexafluoride (SF Chabot G; Bourgault S; Cinq-Mars B; Tourville É; Caissie M Can J Ophthalmol; 2017 Jun; 52(3):269-272. PubMed ID: 28576207 [TBL] [Abstract][Full Text] [Related]
53. Triamcinolone in small-gauge vitrectomy for epiretinal membrane peeling. Angermann R; Zehetner C; Sidoroff P; Waltl I; Kieselbach G; Kralinger M Can J Ophthalmol; 2018 Dec; 53(6):632-636. PubMed ID: 30502990 [TBL] [Abstract][Full Text] [Related]
54. Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study. Georgalas L; Tservakis I; Kiskira EE; Petrou P; Papaconstantinou D; Kanakis M Cutan Ocul Toxicol; 2019 Dec; 38(4):330-337. PubMed ID: 31060385 [No Abstract] [Full Text] [Related]
55. Effectiveness of Intravitreal Dexamethasone Implant Treatment for Diabetic Macular Edema in Vitrectomized Eyes. Özdemir HB; Hasanreisoğlu M; Yüksel M; Ertop M; Gürelik G; Özdek Ş Turk J Ophthalmol; 2019 Dec; 49(6):323-327. PubMed ID: 31893587 [TBL] [Abstract][Full Text] [Related]
56. Efficacy of Combined Vitrectomy with Intravitreal Corticosteroid Injection for Idiopathic Epiretinal Membrane Removal on Anatomical and Functional Outcomes: A Meta-Analysis. Chen HJ; Hsiao CH; Chang CJ Ophthalmologica; 2022; 245(3):218-229. PubMed ID: 35139513 [TBL] [Abstract][Full Text] [Related]
57. Effectiveness of combined macular buckle under direct vision and vitrectomy with ILM peeling in refractory macular hole retinal detachment with extreme high axial myopia: a 24-month comparative study. Ma J; Li H; Ding X; Tanumiharjo S; Lu L Br J Ophthalmol; 2017 Oct; 101(10):1386-1394. PubMed ID: 28292775 [TBL] [Abstract][Full Text] [Related]
58. [Long term clinical observation on postoperative microstructural change of macula lutea in treatment of idiopathic macular epiretinal membrane]. Jiao MF; Liu JP; Chen XT; Li XR Zhonghua Yan Ke Za Zhi; 2018 Apr; 54(4):258-262. PubMed ID: 29747354 [No Abstract] [Full Text] [Related]
59. Visual outcomes after vitrectomy for epiretinal membrane in pseudophakic eyes with a diffractive trifocal intraocular lens: a retrospective cohort study. Arrevola-Velasco L; Beltran J; Gimeno MJ; Ortega-Usobiaga J; Druchkiv V; Llovet-Osuna F; Baviera-Sabater J BMC Ophthalmol; 2022 Jan; 22(1):39. PubMed ID: 35086499 [TBL] [Abstract][Full Text] [Related]
60. Surgical results of idiopathic and secondary epiretinal membrane. Kang KT; Kim KS; Kim YC Int Ophthalmol; 2014 Dec; 34(6):1227-32. PubMed ID: 25331229 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]